Segment Information (Tables)

3 Months Ended

Mar. 31, 2014

Segment Information [Abstract]

Segment Financial Information

The following tables present operating group financial information for the periods indicated:

	Three Months Ended March 31, 2014
	Healthcare		DNA		Total
Net sales:
Software and other	$	11,142	$	3,941	$	15,083
Professional services		7,076		3,413		10,489
Maintenance and EDI		25,011		320		25,331
Total net sales		43,229		7,674		50,903
Expenses		37,213		6,886		44,099
Segment income	$	6,016	$	788		6,804
Net corporate/other expenses (1)						6,498
Income (loss) before income taxes					$	306

	Three Months Ended March 31, 2013
	Healthcare		DNA			Total
Net sales:
Software and other	$	17,825	$	5,746		$	23,571
Professional services		8,055		4,068			12,123
Maintenance and EDI		27,358		582			27,940
Total net sales		53,238		10,396			63,634
Expenses		44,151		10,564			54,715
Segment income (loss)	$	9,087	$	(168	)		8,919
Net corporate/other expenses (1)							12,397
Loss before income taxes						$	(3,478	)

(1)  Net corporate/other expenses include public company costs, corporate administration expenses, amortization expense which is not attributable to business segments, acquisition-related expenses and net interest expense.

	Healthcare		DNA		Corporate/ Other		Consolidated
Depreciation and amortization
Three Months ended March 31, 2014	$	3,282	$	793	$	2	$	4,077
Assets as of March 31, 2014	$	322,115	$	41,972	$	5,466	$	369,553

	Healthcare		DNA		Corporate/ Other		Consolidated
Depreciation and amortization
Three Months ended March 31, 2013	$	3,401	$	1,046	$	16	$	4,463
Restructuring and Other One Time Charges
Three Months ended March 31, 2013	$	1,229	$	-	$	-	$	1,229
Assets as of December 31, 2013	$	333,459	$	42,894	$	5,728	$	382,081